Vivavision Biotech, Inc

This early-stage study tests a new nasal spray called VVN432 in 60 people. First, healthy volunteers will check for safety. Then, patients with chronic sinusitis will test if it helps symptoms. The goal is to see if the spray is safe and how the body processes it.